For patients with chronic, limb-threatening ischemia due to atherosclerosis that affects the arteries below the knee, a revascularization strategy using endovascular treatment as the first option was ...
BACKGROUND: Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly ...
PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)--LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...
A study documents poor outcomes among hospitalized patients with kidney failure and critical limb ischemia who did not receive dialysis. Critical limb ischemia is common among patients with end-stage ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a novel bioresorbable scaffold for the treatment of chronic limb-threatening ischemia. The ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that early ...
For decades, treatment of peripheral artery disease has focused almost exclusively on restoring blood flow. Now, new research ...
Development of a new scaffold based on collagen microgel for next-generation stem cell therapy. Excellent biocompatibility and cell viability increase potential for treating critical limb ischemia.
Persistent over-dilation of muscle microvasculature may be one reason causing chronic limb-threatening ischemia, recent studies by Kuopio University Hospital and the University of Eastern Finland show ...
Women and Black patients are more likely to suffer life-changing complications from advanced heart and blood vessel procedures, a trio of new studies says. Persistent over-dilation of muscle ...
Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results